Synthetic Development and Scale-Up of the Aminoindazole Fragment of Lenacapavir

IF 3.3 3区 化学 Q2 CHEMISTRY, APPLIED
Lennie Lin,Anna M. Wagner,Jason Davy,Chloe Y. Wong,Wen-Tau T. Chang,B. Michael O’Keefe,Alexander F. G. Goldberg,Huy Van Huynh,Hongwei Sun,Wei Wang,Scott A. Wolckenhauer
{"title":"Synthetic Development and Scale-Up of the Aminoindazole\nFragment of Lenacapavir","authors":"Lennie Lin,Anna M. Wagner,Jason Davy,Chloe Y. Wong,Wen-Tau T. Chang,B. Michael O’Keefe,Alexander F. G. Goldberg,Huy Van Huynh,Hongwei Sun,Wei Wang,Scott A. Wolckenhauer","doi":"10.1021/acs.oprd.6c00302","DOIUrl":null,"url":null,"abstract":"Abstract We describe herein the development and scale-up of the aminoindazole fragment of lenacapavir, a drug recently approved for long-acting treatment of HIV (Sunlenca) and pre-exposure prophylaxis (as Yeztugo and Yeytuo). This five-step route to fragment 1 was developed from the initial “fit-for-purpose” large-scale synthesis to a commercially viable process. Key improvements include an alternative condition to hydroxylamine-O-sulfonic acid-mediated nitrile formation and a significant overhaul of the key Miyaura borylation process. The culmination of all development efforts improved the final product quality and process safety, resulting in a more efficient and higher-yielding process.","PeriodicalId":55,"journal":{"name":"Organic Process Research & Development","volume":"31 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic Process Research & Development","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1021/acs.oprd.6c00302","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract We describe herein the development and scale-up of the aminoindazole fragment of lenacapavir, a drug recently approved for long-acting treatment of HIV (Sunlenca) and pre-exposure prophylaxis (as Yeztugo and Yeytuo). This five-step route to fragment 1 was developed from the initial “fit-for-purpose” large-scale synthesis to a commercially viable process. Key improvements include an alternative condition to hydroxylamine-O-sulfonic acid-mediated nitrile formation and a significant overhaul of the key Miyaura borylation process. The culmination of all development efforts improved the final product quality and process safety, resulting in a more efficient and higher-yielding process.
Lenacapavir胺茚唑片段的合成、开发及规模化生产
摘要:本文描述了lenacapavir的氨基吲哚唑片段的开发和扩大规模,lenacapavir是一种最近被批准用于长效HIV治疗(Sunlenca)和暴露前预防(Yeztugo和Yeytuo)的药物。这五步路线片段1从最初的“适合用途”的大规模合成发展到商业上可行的过程。关键的改进包括替代羟胺-邻磺酸介导的腈生成条件和关键的Miyaura硼化工艺的重大改革。所有开发努力的最终结果提高了最终产品的质量和过程安全性,从而产生了更有效和更高产量的过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
14.70%
发文量
251
审稿时长
2 months
期刊介绍: The journal Organic Process Research & Development serves as a communication tool between industrial chemists and chemists working in universities and research institutes. As such, it reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications. Process chemistry is the science that enables the safe, environmentally benign and ultimately economical manufacturing of organic compounds that are required in larger amounts to help address the needs of society. Consequently, the Journal encompasses every aspect of organic chemistry, including all aspects of catalysis, synthetic methodology development and synthetic strategy exploration, but also includes aspects from analytical and solid-state chemistry and chemical engineering, such as work-up tools,process safety, or flow-chemistry. The goal of development and optimization of chemical reactions and processes is their transfer to a larger scale; original work describing such studies and the actual implementation on scale is highly relevant to the journal. However, studies on new developments from either industry, research institutes or academia that have not yet been demonstrated on scale, but where an industrial utility can be expected and where the study has addressed important prerequisites for a scale-up and has given confidence into the reliability and practicality of the chemistry, also serve the mission of OPR&D as a communication tool between the different contributors to the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书